A Phase 2 Study of Bendamustine Plus Melphalan Conditioning for Second Autologous Stem Cell Transplantation in “De-Novo” Multiple Myeloma Patients in a Tandem Transplant Strategy

Category Primary study
JournalBlood
Year 2015
This article has no abstract
Epistemonikos ID: 96b5e15e3076ab8cc2f7866621d469c38d27f6e5
First added on: Feb 19, 2025